Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy).

Michael D. Ezekowitz,Rangadham Nagarakanti,Herbert Noack,Martina Brueckmann,Claire Litherland,Mark Jacobs,Andreas Clemens,Paul A. Reilly,Stuart J. Connolly,Salim Yusuf,Lars Wallentin

Circulation（2016）

引用 28|浏览0

暂无评分

摘要

BACKGROUND: The RE-LY trial (Randomized Evaluation of Long-Term Anticoagulant Therapy) compared dabigatran 150 and 110 mg twice daily with warfarin in 18 113 patients with atrial fibrillation. Thos ...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要